Special clinical interests in urological and gastro intestinal
Clinical Professor Andrew Kneebone has nearly 20 years experience as a prostate cancer specialist and is committed to a caring, and honest relationship with his patients. For more than 10 years he has been an integral member of the national Radiation Oncology Genitourinary executive and has been an author on multiple guidelines for definitive and post prostatectomy radiotherapy.
Professor Kneebone frequently sees patients from across Sydney for second opinions. He regularly publishes Australian results on prostate cancer radiotherapy and continues to collect prospective outcome and toxicity data on all prostate cancer patients, so as to ensure he can provide his patients with the best level of care.
Due to his high profile, Professor Kneebone is on numerous state and national committees related to the treatment of prostate cancer. In addition to being the Convener for seven past national conferences on urological cancer, Professor Kneebone was for six years the Secretary of the NSW Genitourinary Oncology Group.
Professor Kneebone remains a committed teacher to medical students and junior doctors. He is attached to and lectures at the University of Sydney and is the Director of Registrar Training at Royal North Shore Hospital. Professor Kneebone’s has a strong interest in research and has been a Chief Investigator in trials attracting more than $4 million in competitive grants. He was the Principal Investigator, in 2 randomised Australian trials, which were looking at methods to reduce bowel damage arising from prostate radiotherapy and ways to better keep patients still during radiotherapy treatment.
Professor Kneebone is currently the Australian Chair for a multi centre randomised trial which is trying to ascertain the optimal timing for post prostatectomy radiotherapy.